Information from Industry - Sponsored Supplement

Omadacycline: An Oral Antibiotic for the Treatment of Bacterial Skin Infections and Pneumonia in an Era of Unmet Clinical Need

J Fam Pract. 2022 June;71(5)
This supplement was sponsored by Paratek Pharmaceuticals, Inc. It was edited and peer reviewed by The Journal of Family Practice.

 

Despite advances in the management of skin and soft tissue infections and community-acquired pneumonia, challenges persist. This 2-part supplement to The Journal of Family Practice summarizes the findings of 3 phase 3 studies of omadacycline.
 

 

Read More

 

 

Next Article:

Trans teens less likely to commit acts of sexual violence, says new study